CAS: 1216744-19-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK 4112 REF: IN-DA009CI5CAS: 1216744-19-2 | % | A consultar | Mié 22 Ene 25 |
 | GSK4112 REF: TM-T5045CAS: 1216744-19-2 | 99.63% | 35,00 €~421,00 € | Mié 29 Ene 25 |
 | GSK4112 REF: 3D-RYB74419CAS: 1216744-19-2 | Min. 95% | A consultar | Mié 05 Mar 25 |
 | GSK 4112 REF: TR-G797700CAS: 1216744-19-2 | - - - | - - - | Producto descatalogado |
Ref: IN-DA009CI5
| 1g | A consultar | ||
| 10mg | 58,00 € | ||
| 50mg | 142,00 € | ||
| 100mg | 171,00 € |
Entrega estimada en Estados Unidos, el Miércoles 22 de Enero de 2025
GSK4112
CAS:1216744-19-2
GSK4112 (SR6452) is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small …
Fórmula:
C18H21ClN2O4S
Pureza:
99.63%
Forma y color:
Solid
Peso molecular:
396.89
Ref: TM-T5045
| 10mg | 49,00 € | ||
| 25mg | 93,00 € | ||
| 50mg | 169,00 € | ||
| 100mg | 293,00 € | ||
| 200mg | 421,00 € | ||
| 1mL*10mM (DMSO) | 35,00 € |
Entrega estimada en Estados Unidos, el Miércoles 29 de Enero de 2025
GSK4112
CAS:1216744-19-2
GSK4112 is a novel, orally bioavailable compound that is being developed for the treatment of …
Fórmula:
C18H21ClN2O4S
Pureza:
Min. 95%
Peso molecular:
396.89 g/mol
Ref: 3D-RYB74419
| 50mg | 864,00 € | ||
| 100mg | 1.302,00 € |
Entrega estimada en Estados Unidos, el Miércoles 5 de Marzo de 2025
GSK 4112
CAS:1216744-19-2
Applications GSK 4112 is a synthetic ligand for REV-ERBα, a member of the nuclear receptor …
Fórmula:
C18H21ClN2O4S
Forma y color:
Pale Yellow to Light Yellow Solid
Peso molecular:
396.89
Ref: TR-G797700
| 5mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información |
